Revenue, margin and cash expenses missed KBW forecasts as Cipher expanded its Texas development pipeline. A state-ordered review now clouds the interconnection timeline for several proposed campuses.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoint of its full-year revenue guidance, as growth from launched and acquired products helped offset declines in its COVID-19 portfolio. The pharmaceutical company reported...
Ichor's Q2 earnings beat estimates as margin gains offset a revenue miss, while strong demand fuels upbeat 2026 growth and Q3 guidance.
WEN heads into Q2 earnings with Project Fresh, digital initiatives and menu upgrades in focus as investors watch for traffic and margin trends.
GILT heads into Q2 earnings with defense and in-flight connectivity momentum, major orders and a planned acquisition, but execution risks remain in focus.
Shares of one automation technology provider slipped after earnings, while another jumped. The new $13.15 midpoint implies fourth quarter earnings per share of about $3.60. Shares of automation technology provider Zebra Technologies were up 20% at $350 after it reported better-than-expected fiscal second-quarter numbers.
ADTN beats earnings and revenue estimates in Q2 2026 with optical networking sales growth and a growing innovation pipeline supporting its outlook.
Aptiv PLC (NYSE:APTV) reported second-quarter 2026 results that exceeded Wall Street earnings expectations, but its shares fell nearly 4% in pre-market trading after the company issued weaker-than-expected guidance for both the third quarter and the full year. While quarterly performance was solid, investors focused on the softer outlook.
Following triple-digit gains on the major indexes yesterday, we're up another +559 points on the Dow, +221 on the Nasdaq and +6 on the S&P 500.
RDW heads into Q2 earnings with 70.6% projected sales growth and record backlog, but R&D spending may pressure near-term profits.
The S&P 500 Index ($SPX ) (SPY ) today is up +0.73%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.00%. September E-mini S&P futures (ESU26 ) are up +0.72%, and September E-mini Nasdaq futures...
SpaceX will release its quarterly financial report after markets close today and its conference call starts at 4:30 p.m. ET. Similar to Tesla, SpaceX is letting investors submit questions ahead of the call.
STRL tops Q2 earnings and revenue estimates as E-Infrastructure growth, acquisitions and a record backlog drive results and higher 2026 guidance.
ASML Holding raised its interim dividend by 17% year over year, signaling confidence in its cash generation. The company paired the dividend move with strong 2026 revenue guidance, despite ongoing China related risks. The new payout level points to a strengthening income profile for shareholders alongside ASML’s leadership in chipmaking tools. ASML Holding, ticker ENXTAM:ASML, is reinforcing its income story with a higher interim dividend and firmer guidance. The stock trades at €1,419.6,...
In late July 2026, Generac Holdings Inc. reported second-quarter 2026 results showing sales of US$1,173.51 million and net income of US$143.24 million, with both basic and diluted earnings per share from continuing operations rising compared with the same period a year earlier, and it also maintained its full-year 2026 net sales growth guidance in the mid-to-high teens percent range. Alongside these results, a subsequent upgrade to a top-tier analyst rating, driven by higher earnings...
NRG Energy Inc. (NYSE:NRG) reported second-quarter 2026 results that featured stronger-than-expected revenue but earnings that fell short of Wall Street forecasts.
Compute margins and lower cash overhead lifted quarterly EBITDA above expectations, but a statewide interconnection audit adds uncertainty to the planned first-quarter 2027 energization of Hut 8’s contracted Texas campus.
BioNTech (NASDAQ:BNTX) reported second-quarter 2026 revenue of €106 million, down from €261 million a year earlier, as lower U.S. demand for its COVID-19 vaccine weighed on results. The prior-year quarter also benefited from a one-time compensation payment from Pfizer related to its decision to opt
AI data center demand drives 53% revenue growth and record earnings guidance.
RIOT readies for its Aug. 5 Q2 report facing weaker revenue and EPS expectations, but lease revenues and power credits could have helped offset key pressures.

Palantir's (PLTR) second quarter earnings results beat Wall Street's estimates. Morning Brief host Julie Hyman chats with Business Insider executive editor Dan DeFrancesco and Yahoo Finance Breaking Business News Reporter Jake Conley about the results and the valuation.
Palantir just delivered a software quarter that left analysts scrambling for new benchmarks, yet the stock sits far below its peak and the market seems unmoved. Here is what the numbers actually suggest about where shares go from here.
Super Micro (SMCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
On Holding (ONON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prairie Operating Co. (PROP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lumentum (LITE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CoreWeave (CRWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cava (CAVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Venture Global (VG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.